Obesity Surgery

, Volume 22, Issue 6, pp 945–948 | Cite as

Hyperuricemia: a Reality in the Indian Obese

  • Carlyne Remedios
  • Miloni Shah
  • Aparna Govil Bhasker
  • Muffazal Lakdawala
Allied Care


Hyperuricemia is known to be associated with obesity and metabolic syndrome. The aims of this study were to evaluate the prevalence of hyperuricemia in the Indian obese population and to determine if a correlation exists between hyperuricemia, body mass index, waist circumference and components of metabolic syndrome. This was a retrospective observational study. Four hundred nine obese patients were included. Anthropometric parameters were recorded. Prevalence of type 2 diabetes mellitus (T2DM), hypertension and dyslipidemia were recorded. Uric acid levels were measured in all patients. Hyperuricemia was defined as serum uric acid levels greater than 6 mg/dl. The population studied had a median body mass index (BMI) of 44.14 kg/m2 (range 28.1–88.2 kg/m2) and a median age of 41 years (range 18 to 75 years). Overall prevalence of hyperuricemia was 44.6 %. Thirty-four percent in the BMI range of 28–35 kg/m2 and 47 % of patients with a BMI of >35 kg/m2 had hyperuricemia. The incidence of hyperuricemia in males was 50 vs 21.7 % in females. Of patients in the hyperuricemia group, 47.3 % had hypertension as compared to 37 % in the normouricemic group. Dyslipidemia was seen in 7.3 % of hyperuricemic patients as compared to 5.8 % of the normouricemic subjects. The prevalence of T2DM was comparable in both the groups. The Indian obese population has a significant high prevalence of hyperuricemia; the incidence of hyperuricemia in male patients was greater than in female patients. Central obesity had no direct link to hyperuricemia. There was no significant correlation between the occurrence of T2DM and dyslipidemia and hyperuricemia. Hypertension was the only comorbidity seen to occur in conjunction with hyperuricemia.


Hyperuricemia Gout BMI Indian Obese Metabolic syndrome Hypertension 



The authors Carlyne Remedios, Miloni Shah, Aparna G. Bhasker and Muffazal Lakdawala have no conflict of interest in relation to this article.


  1. 1.
    Chen LY, Zhu WH, Chen ZW, et al. Relationship between hyperuricemia and metabolic syndrome. JZUS-B. 2007;8:593–8.CrossRefGoogle Scholar
  2. 2.
    Zhang W, Sun K, Yang Y, et al. Plasma uric acid and hypertension in a Chinese community: prospective study and meta-analysis. Clin Comm. 2009;55:2026–34.Google Scholar
  3. 3.
    Lee MS, Lin SC, Chang HY, et al. High prevalence of hyperuricemia in elderly Taiwanese. Asia Pac J Clin Nutr. 2005;14:285–92.PubMedGoogle Scholar
  4. 4.
    Kowalski J, Krzeminska A, Banach M, et al. The concentration of uric acid in patients with metabolic syndrome and cardiovascular disease. CEJMed. 2009;3:272–8.Google Scholar
  5. 5.
    Schlesinger N. Dietary factors and hyperuricemia. Curr Pharm Design. 2005;11:4133–8.CrossRefGoogle Scholar
  6. 6.
    Ogbera AO. Azenabor AO Hyperuricemia and the metabolic syndrome in type 2 DM. DMS J. 2010;2:1–8.Google Scholar
  7. 7.
    Eggebeen AT. Gout: an update. Am Fam Physician. 2007;76:801–7.PubMedGoogle Scholar
  8. 8.
    Hilaire ML, Wozniak JR. Gout: overview and newer therapeutic developments. Formulary. 2010;45:84–90.Google Scholar
  9. 9.
    Miao Z, Yan S, Wang J, et al. Insulin resistance acts as an independent risk factor exacerbating high-purine diet induced renal injury and knee joint gouty lesions. Inflamm Res. 2009;58:659–68.PubMedCrossRefGoogle Scholar
  10. 10.
    Johnson RJ, Sautin YY, Oliver WJ, et al. Lessons from comparative physiology: could uric acid represent a physiologic alarm signal gone awry in western society? J Comp Physiol B. 2009;179:67–76.PubMedCrossRefGoogle Scholar
  11. 11.
    Pascual E, Sivera F. Gout: new advances in the diagnosis and management of an old disease. Int J Clin Rheumatol. 2009;4:203–20.CrossRefGoogle Scholar
  12. 12.
    Cai Z, Xu X, Wu X, et al. Hyperuricemia and the metabolic syndrome in Hangzhou. Asia Pac J Clin Nutr. 2009;18:81–8.PubMedGoogle Scholar
  13. 13.
    Uaratanawong S, Suraamornkul S, Angkeaw S, et al. Prevalence of hyperuricemia in Bangkok population. Clin Rheumatol. 2011;30:887–93.PubMedCrossRefGoogle Scholar
  14. 14.
    Ford DK. deMOS AM, Serum uric acid levels of healthy Caucasian, Chinese and Haida Indian males in British Columbia. Can Med Assoc J. 1964;90:1295–7.PubMedGoogle Scholar
  15. 15.
    Wen CP. David Cheng TY, Tsai SP, et al. Are Asians at greater mortality risk than Caucasians? Redefining obesity for Asians. Public Health Nutr. 2009;12:497–506.PubMedCrossRefGoogle Scholar
  16. 16.
    Mastuura F, Yamashita S, Nakamura T, et al. effect of visceral fat of uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely top overproduction of uric acid than subcutaneous fat obesity. Metabolism. 1998;47:929–33.CrossRefGoogle Scholar
  17. 17.
    Bonora E, Targher G, Zenere MB, et al. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord. 1996;20:975–80.PubMedGoogle Scholar
  18. 18.
    Jawed S, Khawaja TF, Sultan MA, et al. The effect of essential hypertension on serum uric acid level. Biomedica. 2005;21:98–102.Google Scholar
  19. 19.
    Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension. 2003;42:247–52.PubMedCrossRefGoogle Scholar
  20. 20.
    Peixoto MR, Monego ET, Jardim PC, et al. Diet and medication in the treatment of hyperuricemia in hypertensive patients. Arq Bras Cardiol. 2001;76:468–72.CrossRefGoogle Scholar
  21. 21.
    Krishnan E, Kwoh CK, Schumacher HR, et al. Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension. 2007;49:298–303.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2012

Authors and Affiliations

  • Carlyne Remedios
    • 1
  • Miloni Shah
    • 1
  • Aparna Govil Bhasker
    • 1
    • 2
  • Muffazal Lakdawala
    • 1
    • 2
  1. 1.Centre for Obesity and Diabetes SurgeryMumbaiIndia
  2. 2.Department of Minimal Access and Bariatric SurgerySaifee HospitalMumbaiIndia

Personalised recommendations